Research programme: human monoclonal antibodies - Takeda/Kirin Brewery

Drug Profile

Research programme: human monoclonal antibodies - Takeda/Kirin Brewery

Alternative Names: Human monoclonal antibodies research programme - Takeda/Kirin

Latest Information Update: 30 Jun 2011

Price : $50

At a glance

  • Originator Kirin Brewery; Takeda
  • Class Monoclonal antibodies; Monoclonal antibody diagnostics
  • Mechanism of Action Diagnostic imaging enhancers; Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Unspecified

Most Recent Events

  • 19 Jan 2007 No development reported - Preclinical for Undefined indication (diagnosis) in Japan (unspecified route)
  • 19 Jan 2007 No development reported - Preclinical for Undefined indication in Japan (unspecified route)
  • 07 Aug 2003 Preclinical trials in Undefined indication (diagnosis) in Japan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top